Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

City Therapeutics

Clinical trials sponsored by City Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New shot aims to prevent dangerous clots in High-Risk patients Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New shot aims to prevent dangerous clots in High-Risk patients

Disease control Recruiting now

This early-stage study tests a single injection of CITY-FXI, a drug designed to lower clotting risk by targeting a protein called Factor XI. It includes healthy adults and those with Factor V Leiden or prothrombin G20210A mutations, which increase clot risk. The main goal is to c…

Phase 1 • Sponsor: City Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC